Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction.

ABSTRACT:

Abstract

The use of beta-blockers (BB) in the context of ST-segment elevation myocardial infarction (STEMI) was a universal practice in the pre-reperfusion era. Since then, evidence of their use for secondary prevention after STEMI is scarce. Our aim is to determine treatment results associated with BB therapy after a STEMI at 1-year follow-up in a contemporary nationwide cohort.A prospective analysis involving 49 national centers, including patients admitted with STEMI, enrolled between October 2010 and September 2019 was conducted. The primary outcome was defined as the composite of all-cause mortality or hospital re-admission for a cardiovascular (CV) cause in the first year after STEMI. The patients were distributed into 2 groups, depending on whether they received therapy with

SUBMITTER: Ferreira JA 

PROVIDER: S-EPMC7837933 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature